Stockscreener 앱 받기
0.00
100.00%
-7.87
Chromadex Corp 주식(CDXC)의 최신 뉴스
ChromaDex (NASDAQ:CDXC) Coverage Initiated by Analysts at StockNews.com - Defense World
Niagen Bioscience Confirms Its Operations Remain Unaffected By New Tariffs - MarketScreener
Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs - Business Wire
Niagen Says Its Operations Remain Resilient Amid Recent Tariff Developments - MarketScreener
Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments - BioSpace
Niagen Bioscience maintains stability amid tariffs By Investing.com - Investing.com India
Niagen Bioscience maintains stability amid tariffs - Investing.com Australia
ChromaDex (NASDAQ:CDXC) Coverage Initiated at StockNews.com - Defense World
ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® - MarketScreener
H.C. Wainwright holds $11 target on Niagen Bioscience stock By Investing.com - Investing.com Australia
H.C. Wainwright holds $11 target on Niagen Bioscience stock - Investing.com
Why ChromaDex Corp (CDXC) Is Surging In 2025? - Insider Monkey
Botanical Supplements Market In-depth Insights, Business - openPR.com
Why These 15 Defensive Stocks Are Surging In 2025 - Insider Monkey
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) - Marketscreener.com
Niagen Bioscience secures new patent for NAD+ precursors - Investing.com India
Niagen Bioscience broadens NAD+ precursor IP portfolio with new patent - TipRanks
Niagen Bioscience secures new patent for NAD+ precursors By Investing.com - Investing.com UK
Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms - Business Wire
ChromaDex Completes Name Change to Niagen Bioscience -March 19, 2025 at 09:29 am EDT - Marketscreener.com
Chromadex Rebrands to Niagen Bioscience, Inc. - TipRanks
ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science - The Bakersfield Californian
Chlorinated Isopropane Market Set for 4.9% CAGR Growth, Hitting USD 496.0 Million by 2035 | Fact.MR Report - GlobeNewswire Inc.
ChromaDex Corporation will Change its Name to Niagen Bioscience, Inc -March 19, 2025 at 12:00 am EDT - Marketscreener.com
ChromaDex’s (CDXC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
ChromaDex changes name to Niagen Bioscience to home in on healthy aging - SupplySide Supplement Journal
Chromadex’s Strategic Rebranding and Promising Clinical Developments Justify Buy Rating - TipRanks
ChromaDex rebrands as Niagen Bioscience to reflect growth in supplement, pharmaceutical industries - NutraIngredients-USA.com
ChromaDex Changing Name To Niagen Bioscience While Shifting Focus To Rx NAD+ - insights.citeline.com
ChromaDex to rebrand as Niagen Bioscience and change ticker By Investing.com - Investing.com Australia
Q1 Earnings Forecast for ChromaDex Issued By HC Wainwright - Defense World
ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - BioSpace
ChromaDex to rebrand as Niagen Bioscience and change ticker - Investing.com India
Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science - StockTitan
ChromaDex to Present at the 37th Annual Roth Conference - BioSpace
Healthy Aging Leader ChromaDex Takes Center Stage at ROTH Conference Longevity Panel - StockTitan
ChromaDex (NASDAQ:CDXC) Given New $11.00 Price Target at HC Wainwright - Defense World
ChromaDex stock price target raised to $11 by H.C. Wainwright - Investing.com Australia
Chromadex corp. SVP buys $2,145 worth of common stock - Investing.com
ChromaDex Co. (NASDAQ:CDXC) Shares Bought by Rhumbline Advisers - Defense World
Truist Financial Corp Makes New $54,000 Investment in ChromaDex Co. (NASDAQ:CDXC) - Defense World
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - Defense World
ChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, LADENBURG THALM/SH SH Analyst Says - Defense World
0.49%
1.17%
자본화:
|
볼륨(24시간):